1. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi
by Matthew S. Painschab, Kate D. Westmoreland, Edwards Kasonkanji, Takondwa Zuze, Bongani Kaimila, Peter Waswa, Nader Kim El-Mallawany, Tamiwe Tomoka, Maurice Mulenga, Nathan D. Montgomery, Yuri Fedoriw, and Satish Gopal
BloodAdv
Volume 3(4):
February 26, 2019
© 2019 by The American Society of Hematology

2. Matthew S. Painschab et al. Blood Adv 2019;3:612-620
© 2019 by The American Society of Hematology

3. Representative pathology from a patient with BL
Representative pathology from a patient with BL. Hematoxylin and eosin stain demonstrates typical starry-sky appearance with a diffuse infiltrate of medium-sized lymphocytes and tingible-body macrophages (A), CD20 stains the malignant cells (B), CD10 stains the malignant cells (C), BCL2 is negative in the malignant cells and stains positive in background T lymphocytes (D), TdT is negative (E), and Ki67 is positive (F) in >95% of malignant cells.
Representative pathology from a patient with BL. Hematoxylin and eosin stain demonstrates typical starry-sky appearance with a diffuse infiltrate of medium-sized lymphocytes and tingible-body macrophages (A), CD20 stains the malignant cells (B), CD10 stains the malignant cells (C), BCL2 is negative in the malignant cells and stains positive in background T lymphocytes (D), TdT is negative (E), and Ki67 is positive (F) in >95% of malignant cells. Magnification ×40 for all images.
Matthew S. Painschab et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

4. Flowchart of first-line chemotherapy and outcomes among newly diagnosed patients with BL in Lilongwe, Malawi.
Flowchart of first-line chemotherapy and outcomes among newly diagnosed patients with BL in Lilongwe, Malawi.
Matthew S. Painschab et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

5. Kaplan-Meier curves for OS
Kaplan-Meier curves for OS. OS curves shown for entire cohort (with 95% CI bands) (A), by HIV status (B), by aaIPI (C), and by treatment (CHOP vs more intensive regimens) (D).
Kaplan-Meier curves for OS. OS curves shown for entire cohort (with 95% CI bands) (A), by HIV status (B), by aaIPI (C), and by treatment (CHOP vs more intensive regimens) (D).
Matthew S. Painschab et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology